Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
SGARRO DOUGLAS A
  2. Issuer Name and Ticker or Trading Symbol
CVS CAREMARK CORP [CVS]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Executive Vice President
(Last)
(First)
(Middle)
ONE CVS DRIVE
3. Date of Earliest Transaction (Month/Day/Year)
08/18/2009
(Street)

WOONSOCKET, RI 02895-
4. If Amendment, Date Original Filed(Month/Day/Year)
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/18/2009   M   27,500 A $ 14.9625 197,227.6044 D (3)  
Common Stock 08/18/2009   M   23,726 A $ 14.9625 220,953.6044 D (3)  
Common Stock 08/18/2009   M   61,110 A $ 12.5625 282,063.6044 D (3)  
Common Stock 08/18/2009   S(1)   112,336 D $ 34.5003 (2) 169,727.6044 D (3)  
Common Stock 08/19/2009   M   45,259 A $ 30.2625 214,986.6044 D (3)  
Common Stock 08/19/2009   M   48,890 A $ 12.5625 263,876.6044 D (3)  
Common Stock 08/19/2009   M   70,000 A $ 17.6675 333,876.6044 D (3)  
Common Stock 08/19/2009   M   80,000 A $ 22.445 413,876.6044 D (3)  
Common Stock 08/19/2009   S(1)   244,149 D $ 34.5114 (4) 169,727.6044 D (3)  
Common Stock 08/20/2009   M   24,741 A $ 30.3625 194,468.6044 D (3)  
Common Stock 08/20/2009   S(1)   24,741 D $ 34.5 169,727.6044 D (3)  
Common Stock (restricted)               74,893 D  
ESOP Common Stock               2,160.3254 I By ESOP
Stock Unit               23,668.3172 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $ 14.9625 08/18/2009   M     27,500   (5) 01/02/2012 Common Stock 27,500 $ 0 23,726 D  
Stock Option $ 14.9625 08/18/2009   M     23,726   (5) 01/02/2012 Common Stock 23,726 $ 0 0 D  
Stock Option $ 12.5625 08/18/2009   M     61,110 01/09/2005(6) 01/09/2013 Common Stock 61,110 $ 0 48,890 D  
Stock Option $ 30.2625 08/19/2009   M     45,259 03/07/2003(7) 03/07/2011 Common Stock 45,259 $ 0 24,741 D  
Stock Option $ 12.5625 08/19/2009   M     48,890 01/09/2005(8) 01/09/2013 Common Stock 48,890 $ 0 0 D  
Stock Option $ 17.6675 08/19/2009   M     70,000 01/08/2005(9) 01/08/2011 Common Stock 70,000 $ 0 0 D  
Stock Option $ 22.445 08/19/2009   M     80,000 01/05/2006(10) 01/05/2012 Common Stock 80,000 $ 0 0 D  
Stock Option $ 30.2625 08/20/2009   M     24,741 03/07/2003(11) 03/07/2011 Common Stock 24,741 $ 0 0 D  
Phantom Stock Credits $ 1 (12)               (13)(14)(15)   (13)(14)(15) Common Stock 7,499   7,499 D  
Stock Option $ 30.035             04/03/2007 04/03/2013 Common Stock 147,531   147,531 D  
Stock Option $ 34.42             04/02/2008 04/02/2014 Common Stock 136,089   136,089 D  
Stock Option $ 41.17             04/01/2009 04/01/2015 Common Stock 172,973   172,973 D  
Stock Option $ 28.1             04/01/2010 04/01/2016 Common Stock 192,709   192,709 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
SGARRO DOUGLAS A
ONE CVS DRIVE
WOONSOCKET, RI 02895-
      Executive Vice President  

Signatures

 Douglas A. Sgarro   08/20/2009
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The sale in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
(2) Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $34.50 and $34.51 per share.
(3) Includes dividend reinvestment shares acquired during the course of the year.
(4) Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $34.50 and $34.53 per share.
(5) Option becomes exercisable in three equal annual installments, commencing 1/2/2004.
(6) Option becomes exercisable in three equal annual installments, commencing 1/9/2005.
(7) Option becomes exercisable in three equal annual installments, commencing 3/7/2003.
(8) Option becomes exercisable in three equal annual installments, commencing 1/9/2005.
(9) Option becomes exercisable in three equal annual installments, commencing 1/8/2005.
(10) Option becomes exercisable in three equal annual installments, commencing 1/5/2006.
(11) Option becomes exercisable in three equal annual installments, commencing 3/7/2003.
(12) Each share credit is equivalent to one share; 1-for-1 conversion.
(13) Distribution from a non-qualified deferred compensation plan. Phantom stock credits are payable in cash only, 1-for-1 conversion, at such time as has been elected by the reporting person.
(14) Reflects 2001, 2002 and 2003 year end company match share credits of 442, 55 and 521, respectively, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
(15) Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.